Pharmocann Global Dirección
Dirección controles de criterios 1/4
We currently do not have sufficient information about the CEO.
Información clave
Meir Shimon
Chief Executive Officer (CEO)
₪849.1k
Compensación total
| Porcentaje del salario del CEO | 72.4% |
| Permanencia del CEO | 1.7yrs |
| Participación del CEO | n/a |
| Permanencia media de la dirección | sin datos |
| Promedio de permanencia en la Junta Directiva | 1.7yrs |
Actualizaciones recientes de la dirección
Recent updates
The Returns On Capital At Pharmocann Global (TLV:PMCN) Don't Inspire Confidence
Mar 30
Should You Use Pharmocann Global's (TLV:PMCN) Statutory Earnings To Analyse It?
Feb 04Pharmocann Global Ltd (TLV:PMCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Dec 31
The Returns At Pharmocann Global (TLV:PMCN) Provide Us With Signs Of What's To Come
Nov 26Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -₪10m |
| Mar 31 2024 | n/a | n/a | -₪10m |
| Dec 31 2023 | ₪849k | ₪615k | -₪10m |
Compensación vs. Mercado: Meir's total compensation ($USD226.54K) is below average for companies of similar size in the IL market ($USD427.00K).
Compensación vs. Ingresos: Insufficient data to compare Meir's compensation with company performance.
CEO
Meir Shimon
1.7yrs
Permanencia
₪849,055
Compensación
Mr. Meir Shimon is CEO & Director of Pharmocann Global Ltd from March 15, 2023.
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 1.7yrs | ₪849.06k | sin datos | |
| Chairman of the Board | no data | ₪589.00k | sin datos | |
| Director | 5.4yrs | ₪211.00k | sin datos | |
| External Independent Director | no data | sin datos | sin datos | |
| Independent Director | no data | sin datos | sin datos | |
| External Independent Director | less than a year | sin datos | sin datos |
1.7yrs
Permanencia media
43yo
Promedio de edad
Junta con experiencia: PMCN-M's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.